Showing results (3251-3260 of 3,354) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|January 27, 2024
Psychometric Properties of Child Health Utility 9D (CHU9D) Proxy Version Administered to Parents and Caregivers of Children Aged 2-4 Years Compared with Pediatric Quality of Life Inventory™ (PedsQL)Xiuqin Xiong, Natalie Carvalho, Li Huang, et al.
Pharmacoeconomics|January 27, 2024
An Investigation of Inter-Rater and Intra-Proxy Agreement in Measuring Quality of Life of Children in the Community Using the EQ-5D-Y-3LDiana Khanna, Jyoti Khadka, Christine Mpundu-Kaambwa, et al.
Pharmacoeconomics|March 26, 2024
Developing a Program Costs Checklist of Digital Health Interventions: A Scoping Review and Empirical Case StudyZareen Abbas Khan, Kristian Kidholm, Sindre Andre Pedersen, et al.
Pharmacoeconomics|March 13, 2024
Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European CountriesLaura Panattoni, Mairead Kearney, Natalie Land, et al.
Pharmacoeconomics|September 26, 2024
Valuation of the EORTC Quality of Life Utility Core 10 Dimensions (QLU-C10D) in a Multi-ethnic Asian Setting: How Does Having Cancer Matter?Mihir Gandhi, Ravindran Kanesvaran, Mohamad Farid Bin Harunal Rashid, et al.
Pharmacoeconomics|February 28, 2024
Population Norms for the EQ-5D-5L, PROPr and SF-6D in HungaryAnna Nikl, Mathieu F Janssen, Balázs Jenei, et al.
Pharmacoeconomics|November 13, 2023
Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison StudyRenee Jones, Rachel O'Loughlin, Xiuqin Xiong, et al.
Pharmacoeconomics|July 25, 2023
Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical RecommendationsKumar Mukherjee, Necdet B Gunsoy, Rita M Kristy, et al.
Pharmacoeconomics|July 25, 2023
Estimating the Potential Benefits of Confirmatory Trials for Drugs with Accelerated Approval: A Comprehensive Value of Information FrameworkBoshen Jiao
Pharmacoeconomics|July 13, 2023
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?Nancy J Devlin, Tianxin Pan, Mark Sculpher, et al.
Pageof 336